Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Institute of Cancer Research, United Kingdom

5 clinical trials · 5 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Institute of Cancer Research, United Kingdom

RECRUITINGNCT05097274

The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation.

The aim of the study is to determine if PET-CT imaging (using contrast recommended in clinical guidelines) is superior to combined bone scan and MRI/CT of the abdomen \& pelvis in...

Sponsor: Institute of Cancer Research, United KingdomEnrolling: 501 location
Prostate CancerBRCA MutationMismatch Repair Gene Mutation+4
RECRUITINGNCT03466944

PUMA (Paediatric Osseous Marrow Assessment)

This is a pilot cancer imaging study investigating change in the apparent diffusion coefficient (ADC) at a single time point post-transplantation in patients. The treatment is...

Sponsor: Institute of Cancer Research, United KingdomEnrolling: 121 location
Leukaemia
RECRUITINGPhase 1NCT06632236

5G-EMERALD: Amivantamab in Malignant Brain Tumours

The purpose of this clinical trial is to evaluate the safety and tolerability of amivantamab and to determine the preliminary antitumour activity of amivantamab administered at...

Sponsor: Institute of Cancer Research, United KingdomEnrolling: 122 locations
Malignant Primary GliomasGlioblastoma Multiform (Grade IV Astrocytoma)Diffuse Hemispheric Glioma, H3 G34-Mutant+1
RECRUITINGNCT05968417

Myeloma Novel Drug Discovery Ver 1.2

Myeloma is a bone marrow cancer with over 5000 patients diagnosed in the UK each year. Researchers are committed to improving understanding of myeloma and developing more...

Sponsor: Institute of Cancer Research, United KingdomEnrolling: 2501 location
Multiple Myeloma
RECRUITINGNCT06975579

The COherence of Scatter Identification and Exclusion Algorithm Study

Non-alcoholic fatty liver disease (NAFLD) is currently the most common liver condition worldwide; approximately 55% of the world population will have NAFLD by 2040. NAFLD is an...

Sponsor: Institute of Cancer Research, United KingdomEnrolling: 151 location
Steatohepatitis, Nonalcoholic